170813 ⎘
Detection or diagnosis of diseases; Musculoskeletal or connective tissue disorders Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
COMPOSITIONS, DEVICES, AND METHODS OF OSTEOARTHRITIS SENSITIVITY TESTING
#2COMP PEPTIDE AND ANTIBODIES THERETO FOR DIAGNOSING OSTEOARTHRITIS
#3METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF DEVELOPING A MUSCULOSKELETAL AND/OR CONNECTIVE TISSUE DISEASE
#4BIGLYCAN PEPTIDE AND ANTIBODIES
#5COMPOSITIONS AND METHODS FOR DIAGNOSING AND ASSESSING RHEUMATOID ARTHRITIS
#6ANTI-SULFATASE-RELATED ANTIGEN SPECIFIC ANTIBODY, DETECTION KIT COMPRISING ANTI-SULFATASE-RELATED ANTIGEN SPECIFIC ANTIBODY, AND METHOD FOR DETECTING OSTEOARTHRITIS AND PROGNOSTIC MONITORING OF OSTEOARTHRITIS PROGRESSION BY USING ANTI-SULFATASE-RELATED ANTIGEN SPECIFIC ANTIBODY
#7METHOD FOR DIAGNOSING COLLAGEN DEGRADATION ASSOCIATED DISEASE
#8Antigens Derived from Citrullinated 14-3-3 and Uses Thereof in the Diagnosis of Rheumatoid Arthritis
#9METHODS OF DIAGNOSING AND TREATING OSTEOARTHRITIS
#10Systems and Methods for Angiogenic Treatment in Wound Healing
#11Proteomic Risk Score For Osteoarthritis (OA)
#12ROR2 INHIBITORS AND USE THEREOF IN TREATING AND/OR PREVENTING CARTILAGE LOSS
#13ANTI-OSCAR ANTIBODY FOR PREVENTING OR TREATING OSTEOARTHRITIS
#14SIMULATED SYNOVIAL FLUIDS FOR MODELING DEGENERATIVE JOINT DISEASES AND SCREENING FOR THERAPEUTICS FOR SAME
#15METABOLIC BIOMARKERS FOR PREDICTING RESPONSIVENESS TO FGF-18 COMPOUND
#16FLUORESCENT PROBES FOR DETECTION OF CALCIFICATIONS
#17Composition for treating or diagnosing osteoarthritis targeting ACVR2B
#18METHODS OF TREATING CARTILAGE DISORDERS THROUGH INHIBITION OF CLK AND DYRK
#19BIOMARKERS OF EARLY OSTEOARTHRITIS
#20OSTEOMODULIN AND OSTEOMODULIN FRAGMENTS AS BIOMARKERS FOR OSTEOARTHRITIS AND USE THEREOF
#21Collagen Type X Alpha-1 Assay
#22PRE-SURGICAL DIAGNOSTIC TOOL USING BIOMARKERS TO EVALUATE THE RISK FACTORS OF POST SURGICAL COMPLICATIONS
#23Early detection marker for degenerative osteoarthritis with TRIM24-RIP3 axis
#24ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS
#25Metabolic biomarkers for predicting responsiveness to FGF-18 compound
#26Lateral flow immunoassay strip device
#27IL-18 binding protein (IL-18BP) in inflammatory diseases
#28ROR2 inhibitors and use thereof in treating and/or preventing cartilage loss
#29Compositions and methods for diagnosing and assessing rheumatoid arthritis
#30Systems and methods for angiogenic treatment in wound healing
#31Methods of detecting osteoarthritis and predicting progression thereof
#32Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines
#33ANTI-CARBAMYLATED PROTEIN ANTIBODIES AND THE RISK FOR ARTHRITIS
#34Peptides and compositions for treatment of joint damage
#35Method of early diagnosis of immune-mediated inflammatory disease
#36Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
#37Complex-specific standardization of immunological methods for the quantification of S100A12
#38Peptides and compositions for treatment of joint damage
#39COMPEPTIDE AND ANTIBODIES THERETO FOR DIAGNOSING OSTEOARTHRITIS
#40ANIMAL MODEL FOR STUDYING ZCCHC6 IN BONE DISEASE AND DEVELOPMENT
#41Biomarkers for Cell Therapy
#42COMPOSITIONS, DEVICES, AND METHODS OF OSTEOARTHRITIS SENSITIVITY TESTING
#43Osteomodulin and osteomodulin fragments as biomarkers for osteoarthritis and use thereof
#44MiRNA biomarkers for cartilage degeneration
#45Anti-carbamylated protein antibodies and the risk for arthritis
#46Micro- and nano-device for cartilage injury detection and treatment
#47MEl'hods and means for diagnosing spondylarthritis using autoantibody markers
#48Peptides and compositions for treatment of joint damage
#49Immunoassays of s-adenosylmethionine and methylation index in personalized medicine and health evaluation
#50Peptides and compositions for treatment of joint damage
#51Prophylactic agent and therapeutic agent for fibrodysplasia ossificans progressiva
#52Antibody
#53METHODS AND COMPOUNDS FOR THE TREATMENT OF BONE LOSS AND/OR PAIN
#54Methods for treating inflammatory and other diseases and the use of biomarkers as predictors of clinical sensitivity to treatment with apremilast
#55Biomarkers of osteoarthritis
#56METHODS AND SYSTEM FOR DETERMINING THE DISEASE STATUS OF A SUBJECT
#57Peptides and compositions for treatment of joint damage
#58Magnetic apparatus and methods of use
#59Methods for diagnosing osteoarthritis
#60Biomarkers for Cell Therapy
#61Peptides and compositions for treatment of joint damage
#62METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS
#63IL-18 binding protein (IL-18BP) in inflammatory diseases
#64Methods and means for treatment of osteoarthritis
#65Collagen Type X Alpha-1 Assay
#66Medical image processing apparatus and method for medical image processing
#67Immunoassays of S-adenosylmethionine and methylation index in personalized medicine and health evaluation
#68Methods for the treatment of autoimmune diseases
#69REAGENT FOR DIAGNOSIS OF OSTEOARTHRITIS COMPRISING PEPTIDE PROBE OF APOPEP-1
#70TMEM120A ion channel modulator
#71Determining pathological cartilage turnover
#72Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments
#73Systems and methods for angiogenic treatment in wound healing
#74METHODS FOR DIAGNOSING OSTEOARTHRITIS
#75METHODS FOR DIAGNOSING OSTEOARTHRITIS
#76Methods and kits for diagnosing osteoarthritis and predicting progression
#77Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
#78METHODS AND KITS FOR DIAGNOSING AND/OR PROGNOSING OSTEOARTHRITIS
#79Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
#80Anti-carbamylated protein antibodies and the risk for arthritis
#81Biomarkers of osteoarthritis
#82Hybridoma cell line for producing antibody for type II collagen
#83Methods and means for diagnosing spondylarthritis using autoantibody markers
#84Methods for modulating skeletal remodeling and patterning by modulating SHN2 activity, SHN3 activity, or SHN2 and SHN3 activity in combination
#85Methods for the diagnosis, control and prophylaxis of inflammation and mitigation of inflammatory conditions in canines
#86OSTEOARTHRITIS BIOMARKERS AND USES THEREOF
#87Prevention and treatment of osteoarthritis
#88Variants of C-type natriuretic peptide
#89Indian Hedgehog (Ihh) as a Marker to Predict Osteoarthritis (OA) and Methods for the Prevention and Treatment of OA
#90Method and means for treatment of osteoarthritis
#91PROTEIN BIOMARKERS AND THERAPEUTIC TARGETS FOR OSTEOARTHRITIS
#92Secreted phospholipase A2 biomarkers for arthritis
#93Methods and kits for diagnosing osteoarthritis and predicting progression
#94Quantifying local inflammatory activity and its use to predict disease progression and tailor treatments
#95Methods and means for treatment of osteoarthritis
#96Naphthalene-based inhibitors of anti-apoptotic proteins
#97Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic B-cell lymphoma/leukemia-2 (BCL-2)
#98System and Method for Determining Concentration of a Predetermined Osteoarthritis Biomarker in a Urine Sample
#99Assay for Detecting Cathepsin K Activty in Bone, Cartilage and/or Soft Tissue
#100ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF ISOMERISED NEO-EPITOPE CONTAINING FRAGMENTS
#101ASSESSMENT OF PROTEIN DEGRADATION BY MEASUREMENT OF COLLAGEN FRAGMENTS
#102ASSESSMENT OF SUBCHONDRAL BONE REMODELLING BY MEASURING CATHEPSIN K FRAGMENTS OF COLLAGEN TYPE II
#103BIOMARKERS OF OSTEOARTHRITIS
#104BONE MINERAL DENSITY RATIOS AS A PREDICTOR OF OSTEOARTHRITIS
#105BIOMARKER FOR OSTEOARTHRITIS AND/OR OTHER AGEING-RELATED DISEASES, AND USE THEREOF
#106Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof
#107Method of detecting articular cartilage degeneration or damage
#108Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
#109Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
#110OSTEOARTHRITIS-SENSITIVE GENE
#111MARKERS OF MATRIX GENE EXPRESSION AND CELLULAR DIFFERENTIATION IN CHONDROCYTES
#112Methods and compositions for diagnosing osteoarthritis in a feline
#113Diagnostic assay for human matrix GLA-protein and its use as a biomarker
#114Variants of C-type natriuretic peptide
#115PROTEIN PROFILE FOR OSTEOARTHRITIS
#116Naphthalene-based inhibitors of anti-apoptotic proteins
#117GENE SENSITIVE TO BONE/JOINT DISEASE AND USE THEREOF
#118DIAGNOSTIC METHOD AND PROGNOSTIC TOOL FOR OSTEOARTHRITIS
#119Method for Predicting the Response of a Patient to Treatment with an Anti-TNF Alpha Antibody
#120METHODS FOR EVALUATING OSTEOARTHRITIS RISK
#121Osteoarthritis biomarkers and uses thereof
#122Treatment and diagnosis of abnormal bone density with an inhibitor of the glypican-sclerostin interaction
#123METHOD AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
#124METHODS FOR DIAGNOSING OSTEOARTHRITIS
#125Methods for Identifying FZD8 Modulators and the Use of such Modulators for Treating Osteoarthritis
#126Methods and Compositions Related to TR4
#127Prevention and treatment of osteoarthritis
#128AGENTS AND METHODS FOR DIAGNOSING OSTEOARTHRITIS
#129Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#130METHODS FOR DETERMINING THE ACTIVITY OF ADAM-TS PROTEASES USING THIOPEPTOLIDES
#131Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases
#132Therapeutic angiogenesis for treatment of the spine
#133Bone/joint disease sensitivity gene and use thereof
#134Methods of diagnosing osteoarthritis
#135Use of LXR agonists for the treatment of osteoarthritis
#136Association Between the Tdoa Gene and Osteoarthritis
#137Use of Serum/Glucocorticoid-Regulated Kinase
#138Diagnostic Methods Based on Polymorphisms of Glucosyltransferase-Like Protein
#139Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions
#140Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
#141Methods of Using Bone Morphogenic Proteins as Biomarkers for Determining Cartilage Degeneration and Aging
#142Methods and apparatus for multi dimension fluorescence spectrum measurement downhole
#143GENES ASSOCIATED WITH OSTEOARTHRITIS
#144Methods for inhibiting osteoclastic bone resorption and bone loss comprising administration of an anti-FSH or anti-FSHR antibody
#145Three-dimensional culture containing human articular chondrocytes with induced terminal differentiation changes and preparation process and uses of the same
#146Compositions and Methods of Use for a Fibroblast Growth Factor
#147Genes associated with canine osteoarthritis and related methods and compositions
#148Uncoupled collagen synthesis and degradation assays
#149Methods of diagnosing and treating rheumatoid arthritis and osteoarthritis
#150Fibroblast Growth Factor Receptors 1,2,3, and 4 as Targets for Therapeutic Intervention
#151ISLR gene and its association with osteoarthritis and other bone and cartilage disorders, expression products derived therefrom, and uses thereof
#152Methods for evaluating osteoarthritis risk
#153Method of diagnosing osteoarthritis
#154Methods and compositions targeting tyrosine kinases for the diagnosis and treatment of osteoarthritis
#155Antibodies, assays and kits to quantitate cartilage destruction
#156Computer systems and methods for inferring casuality from cellular constituent abundance data
#157Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
#158Methods of using bone morphogenic proteins as biomarkers for determining cartilage degeneration and aging
#159Method and means for treatment of osteoarthritis
#160Computer systems and methods for inferring causality from cellullar constituent abundance data
#161Azulene dimer-quenched, near-infrared fluorescent probes
#162Method of diagnosing osteolysis
#163Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases
#164Use of TF antagonists
#165Osteoarthritis biomarkers and uses thereof
#166Superficial zone protein-binding molecules and uses thereof
#167Isle gene and its association with osteoarthritis and other bone and cartilage disorders expression products derived therefrom and uses thereof
#168Assays for evaluating anti-osteoarthritic activity
#169Assay for YKL-40 as a marker for degradation of mammalian connective tissue matrices